Functional Characterization of Six

Humans Finland HEK293 Cells Hydroxymethylglutaryl-CoA Reductase Inhibitors Liver-Specific Organic Anion Transporter 1 / genetics Psychotic Disorders Rosuvastatin Calcium
OATP1B1 SLCO1B1 drug transporter organic anion transporting polypeptide 1B1 pharmacogenetics

Journal

Molecular pharmaceutics
ISSN: 1543-8392
Titre abrégé: Mol Pharm
Pays: United States
ID NLM: 101197791

Informations de publication

Date de publication:
06 03 2023
Historique:
pubmed: 14 2 2023
medline: 8 3 2023
entrez: 13 2 2023
Statut: ppublish

Résumé

Variants in the

Identifiants

DOI: 10.1021/acs.molpharmaceut.2c00715 PMID: 36779498 PMC: PMC9996821
pubmed: 36779498
doi: 10.1021/acs.molpharmaceut.2c00715
pmc: PMC9996821
doi:

Substances chimiques

Hydroxymethylglutaryl-CoA Reductase Inhibitors 0
Liver-Specific Organic Anion Transporter 1 0
Rosuvastatin Calcium 83MVU38M7Q
SLCO1B1 protein, human 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1500-1508

Références

Clin Pharmacol Ther. 2022 May;111(5):1007-1021
pubmed: 35152405
Brief Funct Genomics. 2016 Sep;15(5):374-84
pubmed: 26654982
Pharmacogenet Genomics. 2005 Jul;15(7):513-22
pubmed: 15970799
Nature. 2020 May;581(7809):434-443
pubmed: 32461654
Eur J Pharm Sci. 2022 Sep 1;176:106246
pubmed: 35752377
Nature. 2016 Aug 17;536(7616):285-91
pubmed: 27535533
World J Psychiatry. 2021 Oct 19;11(10):696-710
pubmed: 34733637
Pharmacol Rev. 2011 Mar;63(1):157-81
pubmed: 21245207
Nucleic Acids Res. 2019 Jan 8;47(D1):D886-D894
pubmed: 30371827
Neuropsychiatr Dis Treat. 2016 Mar 31;12:719-35
pubmed: 27099503
Curr Protoc Bioinformatics. 2013;43:11.10.1-11.10.33
pubmed: 25431634
Mol Pharm. 2017 Mar 6;14(3):605-613
pubmed: 28112518
Protein J. 2009 Feb;28(2):74-86
pubmed: 19280326
Bioinformatics. 2009 Jul 15;25(14):1754-60
pubmed: 19451168
Am J Med Genet. 1997 Jul 25;74(4):353-60
pubmed: 9259368
Hum Genomics. 2010 Oct;5(1):61-72
pubmed: 21106490
Trends Pharmacol Sci. 2016 Feb;37(2):85-86
pubmed: 26705087
N Engl J Med. 2008 Aug 21;359(8):789-99
pubmed: 18650507
Genome Biol. 2016 Jun 06;17(1):122
pubmed: 27268795
Am Heart J. 2013 Jun;165(6):1008-14
pubmed: 23708174
Genome Res. 2010 Sep;20(9):1297-303
pubmed: 20644199
Am J Physiol Gastrointest Liver Physiol. 2000 Jan;278(1):G156-64
pubmed: 10644574
NPJ Genom Med. 2020 Mar 5;5:9
pubmed: 32194983
Genet Med. 2017 Jan;19(1):20-29
pubmed: 27101133
Pharmacogenomics. 2008 Jan;9(1):19-33
pubmed: 18154446
Fluids Barriers CNS. 2013 Jun 08;10(1):21
pubmed: 23758935
Pharm Res. 2021 Oct;38(10):1663-1675
pubmed: 34647232
Mol Pharm. 2020 Oct 5;17(10):3748-3758
pubmed: 32845645
Clin Pharmacol Ther. 2010 Jan;87(1):130-3
pubmed: 19890253
J Clin Psychiatry. 2004;65 Suppl 7:4-18; quiz 19-20
pubmed: 15151456
Clin Pharmacol Ther. 2014 Oct;96(4):423-8
pubmed: 24918167
J Membr Biol. 2005 Dec;208(3):213-27
pubmed: 16648940
Genome Res. 2012 Jan;22(1):1-8
pubmed: 22147369
Nat Genet. 2014 Mar;46(3):310-5
pubmed: 24487276
J Clin Med. 2019 Dec 20;9(1):
pubmed: 31861911
Bioinformatics. 2014 Mar 15;30(6):884-6
pubmed: 24162465
Int J Pharm. 2019 Nov 25;571:118714
pubmed: 31610281

Auteurs

Katja Häkkinen (K)

Department of Forensic Psychiatry, Niuvanniemi Hospital, University of Eastern Finland, Kuopio FI-70240, Finland.
Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki FI-00014, Finland.
ORCID: 0000-0001-8222-7505

Wilma Kiander (W)

Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, Helsinki FI-00014, Finland.

Heidi Kidron (H)

Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, Helsinki FI-00014, Finland.
ORCID: 0000-0001-6427-8042

Markku Lähteenvuo (M)

Department of Forensic Psychiatry, Niuvanniemi Hospital, University of Eastern Finland, Kuopio FI-70240, Finland.

Lea Urpa (L)

Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki FI-00014, Finland.
ORCID: 0000-0002-8712-3518

Jonne Lintunen (J)

Department of Forensic Psychiatry, Niuvanniemi Hospital, University of Eastern Finland, Kuopio FI-70240, Finland.
ORCID: 0000-0001-5627-2388

Kati-Sisko Vellonen (KS)

School of Pharmacy, University of Eastern Finland, Kuopio FI-70211, Finland.

Seppo Auriola (S)

School of Pharmacy, University of Eastern Finland, Kuopio FI-70211, Finland.

Minna Holm (M)

Mental Health Team, Finnish Institute for Health and Welfare, Helsinki FI-00271, Finland.

Kaisla Lahdensuo (K)

Mehiläinen Ltd, Helsinki FI-00260, Finland.

Olli Kampman (O)

Faculty of Medicine and Health Technology, Tampere University, Tampere FI-33100, Finland.
Department of Psychiatry, Pirkanmaa Hospital District, Tampere FI-33521, Finland.
Department of Clinical Sciences (Psychiatry), Faculty of Medicine, Umeå University, Umeå SE-90187, Sweden.
Department of Psychiatry, University Hospital of Umeå, Umeå SE-90187, Sweden.
Department of Clinical Medicine (Psychiatry), Faculty of Medicine, University of Turku, Turku FI-20014, Finland.
Department of Psychiatry, The Wellbeing Services County of Ostrobothnia, Vaasa FI-65101, Finland.

Erkki Isometsä (E)

Department of Psychiatry, University of Helsinki and Helsinki University Hospital, Helsinki FI-00014, Finland.

Tuula Kieseppä (T)

Mental Health Team, Finnish Institute for Health and Welfare, Helsinki FI-00271, Finland.
Department of Psychiatry, University of Helsinki and Helsinki University Hospital, Helsinki FI-00014, Finland.

Jouko Lönnqvist (J)

Mental Health Team, Finnish Institute for Health and Welfare, Helsinki FI-00271, Finland.
Department of Psychiatry, University of Helsinki, Helsinki FI-00014, Finland.

Jaana Suvisaari (J)

Mental Health Team, Finnish Institute for Health and Welfare, Helsinki FI-00271, Finland.
ORCID: 0000-0001-7167-0990

Jarmo Hietala (J)

Department of Psychiatry, University of Turku and Turku University Hospital, Turku FI-20700, Finland.

Jari Tiihonen (J)

Department of Forensic Psychiatry, Niuvanniemi Hospital, University of Eastern Finland, Kuopio FI-70240, Finland.
Department of Clinical Neuroscience, Karolinska Institutet, Stockholm SE-17177, Sweden.
Center for Psychiatry Research, Stockholm City Council, Stockholm SE-11364, Sweden.
Neuroscience Center, University of Helsinki, Helsinki FI-00014, Finland.

Aarno Palotie (A)

Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki FI-00014, Finland.
The Stanley Center for Psychiatric Research and Program in Medical and Population Genetics, The Broad Institute of MIT and Harvard, Cambridge, Massachusetts 02142, United States.
Analytic and Translational Genetics Unit, Department of Medicine, Department of Neurology and Department of Psychiatry, Massachusetts General Hospital, Boston MA-02114, United States.

Ari V Ahola-Olli (AV)

Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki FI-00014, Finland.
The Stanley Center for Psychiatric Research and Program in Medical and Population Genetics, The Broad Institute of MIT and Harvard, Cambridge, Massachusetts 02142, United States.
Department of Internal Medicine, Satasairaala Hospital, Pori FI-28500, Finland.

Mikko Niemi (M)

Department of Clinical Pharmacology, University of Helsinki, Helsinki FI-00014, Finland.
Individualized Drug Therapy Research Program, Faculty of Medicine, University of Helsinki, Helsinki FI-00014, Finland.
Department of Clinical Pharmacology, HUS Diagnostic Center, Helsinki University Hospital, Helsinki FI-00029, Finland.
ORCID: 0000-0003-4550-2189

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Functional Characterization of Six
questionsmedicales.fr › Régions géographiques › Europe › Pays nordiques et scandinaves › Finlande › Functional Characterization of Six
questionsmedicales.fr › Cellules › Cellules épithéliales › Cellules HEK293 › Functional Characterization of Six
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Agents régulateurs du métabolisme des lipides › Hypolipémiants › Anticholestérolémiants › Inhibiteurs de l'hydroxyméthylglutaryl-CoA réductase › Functional Characterization of Six
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines membranaires › Protéines de transport membranaire › Protéines transporteurs de solutés › Polypeptide C de transport d'anions organiques › Functional Characterization of Six
questionsmedicales.fr › Troubles mentaux › Schizophrénie et troubles avec traits psychotiques › Troubles psychotiques › Functional Characterization of Six
questionsmedicales.fr › Composés hétérocycliques › Composés hétéromonocycliques › Pyrimidines › Rosuvastatine de calcium › Functional Characterization of Six